These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1320569)

  • 1. Shortcomings of the present classification system of anti-arrhythmic drugs.
    Weirich J; Antoni H
    Eur Heart J; 1992 Jun; 13(6):862-3. PubMed ID: 1320569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiac arrhythmias (III). The classification of anti-arrhythmia drugs in the 90s: a focus for the cardiologist].
    Tamargo J; Valenzuela C; Delpón E
    Rev Esp Cardiol; 1993 Mar; 46(3):183-94. PubMed ID: 8387683
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sodium channels and anti-arrhythmia agents. Time for a new classification?].
    Elinder F; Arhem P
    Lakartidningen; 1993 Dec; 90(50):4545-9. PubMed ID: 8264290
    [No Abstract]   [Full Text] [Related]  

  • 4. [New classification of anti-arrhythmia agents according to the effects on ion channels].
    Hiraoka M
    Nihon Naika Gakkai Zasshi; 1991 Dec; 80(12):1975-80. PubMed ID: 1725177
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-arrhythmia agents: classification, mode of action, and therapeutic usefulness].
    Tamargo J; Delpón E; Valenzuela C; Pérez O
    Rev Clin Esp; 1993 Mar; 192(4):189-96. PubMed ID: 8386844
    [No Abstract]   [Full Text] [Related]  

  • 6. The Sicilian Gambit and antiarrhythmic drug development.
    Colatsky TJ
    Cardiovasc Res; 1992 Jun; 26(6):562-5. PubMed ID: 1333361
    [No Abstract]   [Full Text] [Related]  

  • 7. Putting the Sicilian Gambit to the test.
    Janse MJ
    Eur Heart J; 1992 Nov; 13 Suppl F():30-7. PubMed ID: 1335870
    [No Abstract]   [Full Text] [Related]  

  • 8. Symposium: pharmacology of class I anti-arrhythmic agents. Introduction: electrophysiological, biochemical and clinical considerations.
    Man RY
    Clin Invest Med; 1991 Oct; 14(5):444-6. PubMed ID: 1660366
    [No Abstract]   [Full Text] [Related]  

  • 9. [The working classification of antiarrhythmic drugs based on the pathogenetic approach to treatment of cardiac arrhythmias].
    Lipnitskiĭ TN; Kozlovskiĭ VA
    Lik Sprava; 2002; (8):26-30. PubMed ID: 12669534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Models of drug interaction with the sodium channel.
    Grant AO
    Clin Invest Med; 1991 Oct; 14(5):447-57. PubMed ID: 1660367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiarrhythmic agents. Receptor hypothesis explains mechanisms of action].
    Bjørnstad H; Refsum H
    Tidsskr Nor Laegeforen; 1991 Oct; 111(26):3187-9. PubMed ID: 1658976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rational scientific basis for subclassification of antiarrhythmic drugs.
    Harrison DC
    Trans Am Clin Climatol Assoc; 1986; 97():43-52. PubMed ID: 3837966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modulated receptor hypothesis of action of antiarrhythmic drugs].
    Inoue H; Sugimoto T
    Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1917-24. PubMed ID: 2173035
    [No Abstract]   [Full Text] [Related]  

  • 14. Class I anti-arrhythmic drugs: structure and function at the cardiac sodium channel.
    Sheldon RS; Duff HJ; Hill RJ
    Clin Invest Med; 1991 Oct; 14(5):458-65. PubMed ID: 1660368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discussion of "Why do some drugs preferentially block open sodium channels?": consideration of other significant factors in the binding process.
    Rhodes DG; Herbette LG
    J Mol Cell Cardiol; 1988 Jun; 20(6):571-2. PubMed ID: 2851056
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential analysis of frequency-dependent effects of antiarrhythmic drugs: importance of the saturation behavior of frequency-dependent sodium-channel blockade.
    Weirich J; Hohnloser S; Antoni H
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S8-16. PubMed ID: 1279314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiovascular and antiarrhythmic properties of a series of novel sparteine analogs.
    Pugsley MK; Walker MJ; Garrison GL; Howard PG; Lazzara R; Patterson E; Penz WP; Scherlag BJ; Berlin KD
    Proc West Pharmacol Soc; 1992; 35():87-91. PubMed ID: 1323855
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-arrhythmia agents].
    Bracchi G; Vezzoli F
    Clin Ter; 1976 Jul; 78(1):65-85. PubMed ID: 1009752
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-arrhythmic drugs and maximum driving frequency of isolated guinea-pig auricles.
    Wellens D; Dessy F; De Klerk L
    Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):411-4. PubMed ID: 4396927
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current classification of anti-arrhythmia agents].
    Weirich J; Wenzel W
    Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.